Shanghai Junshi Biosciences Co.Ltd(688180) : se acepta la solicitud de ensayo clínico de medicamentos js113

abril 1, 2022

Shanghai Junshi Biosciences Co.Ltd(688180) ( Shanghai Junshi Biosciences Co.Ltd(688180) ) anunció el 1 de abril que Suzhou junjing Biological Medicine, una subsidiaria de control, recibió la notificación de aceptación aprobada y emitida por la administración estatal de drogas, y la solicitud de ensayo clínico de wj13404 comprimidos (Código de proyecto “js113”) fue aceptada.

- Advertisment -

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Siempre activado

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duración	Descripción
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Shanghai Junshi Biosciences Co.Ltd(688180) : se acepta la solicitud de ensayo clínico de medicamentos js113

¡Tolerancia cero! ¡Acción reglamentaria fuerte! Estas dos empresas pueden ser excluidas de...

¡Rayos! El beneficiario final de la empresa ha desaparecido. Posiblemente involucrado en u...

El presidente del consejo de administración de “Tooth Maw” fue archivado por l...

Kalite: Anuncio de oferta pública inicial de acciones y cotización en el GEM

Matriz: Dictamen jurídico del bufete de abogados Guoco (Shenzhen) sobre la oferta pública ...

Weigang Technology: Folleto de oferta pública inicial

Weigang Technology: Anuncio de oferta pública inicial de acciones

Weigang Technology: Resumen del folleto de la oferta pública inicial

Weigang Technology: Anuncio especial sobre los riesgos de inversión de la oferta pública i...

601136:Primera oferta pública de acciones de Capital Securities Primer anuncio especial so...

601136:Anuncio del resultado de la cotización preliminar y aplazamiento de la oferta públi...